Privium Fund Management B.V. Pro Qr Therapeutics N.V. Transaction History
Privium Fund Management B.V.
- $401 Million
- Q3 2024
A detailed history of Privium Fund Management B.V. transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Privium Fund Management B.V. holds 5,632,388 shares of PRQR stock, worth $15 Million. This represents 2.56% of its overall portfolio holdings.
Number of Shares
5,632,388
Previous 5,580,725
0.93%
Holding current value
$15 Million
Previous $9.26 Million
10.64%
% of portfolio
2.56%
Previous 2.62%
Shares
5 transactions
Others Institutions Holding PRQR
# of Institutions
52Shares Held
17.4MCall Options Held
37.7KPut Options Held
21.3K-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$9.68 Million0.01% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.84MShares$4.9 Million0.14% of portfolio
-
M28 Capital Management LP Stamford, CT1.02MShares$2.72 Million1.76% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA906KShares$2.42 Million0.42% of portfolio
-
Ghost Tree Capital, LLC New York, NY888KShares$2.37 Million0.61% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $191M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...